TABLE 2.
Perioperative and postoperative complications in two groups.
| Complication | LAF group | Control group | OR [CI 95] | p |
| IOH, n (%) | 21 (4.5%) | 18 (3.8%) | 0.7 [0.4: 1.4] | >0.05 |
| Irvin Gass, n (%) | 10 (2.1%) | 10 (2.1%) | 1 [0.4: 2.7] | >0.05 |
| PCR, n (%) | 0 (0%) | 6 (1.3%) | 0 | >0.05 |
| Endophthalmitis, n (%) | 0 (0%) | 1 (0.2%) | 0 | >0.05 |
| TASS, n (%) | 0 (0%) | 1 (0.2%) | 0 | >0.05 |
| Floppy iris, n (%) | 2 (0.4%) | 0 (0%) | ∞ | |
| Persistence crystalline mass, n (%) | 1 (0.2%) | 3 (0.6%) | 0.3 [0: 3.3] | >0.05 |
| Corneal edema, n (%) | 1 (0.2%) | 4 (0.8%) | 0.25 [0: 2.25] | >0.05 |
| Hypaema, n (%) | 1 (0.2%) | 0 (0%) | ∞ | |
| Total, n (%) | 36 (7.7%) | 43 (9%) | 0.8 [0.5: 1.3] | >0.05 |
LAF, laminar air flow device; N, number; OR, odds ratio; CI 95, confidence interval at 95%; IOH, intra-ocular hypertension; PCR, posterior capsule rupture; TASS, toxic anterior segment syndrome.